Support PenkeAtara Biotherapeutics Inc - Trending symbols
Notifications
| Type | Notification | Date |
|---|---|---|
| Bullish Engulfing | Bullish Engulfing Candle Pattern | 2025-01-23 |
Trends
| 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Other Comprehensive Income | -571 | 367 | -204 | 149 | -55 | 41 | -14 | 36 | 22 | |
| Interest Expense | 1,395 | -219 | 1,176 | -23 | 1,153 | 109 | 1,262 | -2,445 | -1,183 | |
| Net Working Capital | 216,164 | -59,858 | 156,306 | -58,538 | 97,768 | -58,161 | 39,607 | -79,964 | -40,357 | |
| Depreciation and Amortization | 3,732 | 3,338 | 7,070 | 1,262 | 8,332 | 1,013 | 9,345 | -59,582 | -50,237 | |
| Total Stockholder Equity | 187,113 | -60,473 | 126,640 | -61,680 | 64,960 | -57,506 | 7,454 | -58,292 | -50,838 | |
| Net Invested Capital | 187,113 | -60,473 | 126,640 | -61,680 | 64,960 | -57,506 | 7,454 | -58,292 | -50,838 | |
| Tax Provision | 10 | -8 | 2 | 20 | 22 | -21 | 1 | -20 | -19 | |
| Net Interest Income | 541 | 428 | 969 | -700 | 269 | 48 | 317 | -494 | -177 | |
| Income Tax Expense | 10 | -8 | 2 | 20 | 22 | -21 | 1 | -20 | -19 | |
| Net Tangible Assets | 187,113 | -60,473 | 126,640 | -61,680 | 64,960 | -57,506 | 7,454 | -58,292 | -50,838 | |
| Gross Profit | 51,579 | -47,120 | 4,459 | -4,238 | 221 | 789 | 1,010 | -2,948 | -1,938 | |
| Total Other Income Expense Net | 50,598 | -50,057 | 541 | 428 | 969 | -700 | 269 | -279 | -10 | |
| Net Debt | -84,216 | 77,527 | -6,689 | 2,647 | -4,042 | -17,196 | -21,238 | 27,415 | 6,177 | |
| Income before Tax | -83,777 | -887 | -84,664 | -8,655 | -93,319 | 5,214 | -88,105 | 106,571 | 18,466 | |
| Net Income | -83,793 | -871 | -84,664 | -8,685 | -93,349 | 5,244 | -88,105 | 106,571 | 18,466 | |
| EBIT | -83,777 | -887 | -84,664 | -8,655 | -93,319 | 5,329 | -87,990 | 106,817 | 18,827 | |
| EBITDA | -81,459 | -888 | -82,347 | -8,484 | -90,831 | 4,432 | -86,399 | 106,664 | 20,265 | |
| Net Income from Continuing Operations | -83,793 | -871 | -84,664 | -8,685 | -93,349 | 5,244 | -88,105 | 106,571 | 18,466 | |
| Net Income Applicable to Common Shares | -83,793 | -871 | -84,664 | -8,685 | -93,349 | 5,244 | -88,105 | 106,571 | 18,466 | |
| Other Stockholders Equity | 1,601,784 | 16,393 | 1,618,177 | 63,304 | 1,681,481 | 63,214 | 1,744,695 | -1,746,587 | -1,892 |
Comments
How you think about this?